NYSE: RCUS
Arcus Biosciences Inc Stock Ownership - Who owns Arcus Biosciences?

Insider buying vs selling

Have Arcus Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alexander AzoyCAO2026-08-212,827$15.44
$43.65kBuy
Alexander AzoyCAO2026-08-212,827$30.00
$84.81kSell
Juan C. JaenPresident2026-07-10268$29.40
$7.88kSell
Juan C. JaenPresident2026-07-1019,799$28.61
$566.41kSell
Juan C. JaenPresident2026-07-0948,502$30.05
$1.46MSell
Juan C. JaenPresident2026-06-246,431$29.66
$190.74kSell
Juan C. JaenPresident2026-06-2314,067$27.69
$389.49kSell
Juan C. JaenPresident2026-06-231,697$28.06
$47.62kSell
Juan C. JaenPresident2026-06-229,236$27.03
$249.66kSell
Carolyn C. TangGeneral Counsel2026-06-1134,090$2.57
$87.75kBuy

1 of 6

RCUS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCUS insiders and whales buy or sell their stock.

RCUS Shareholders

What type of owners hold Arcus Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc24.68%31,424,760$802.59MInsider
Terry J. Rosen11.32%14,413,895$368.13MInsider
Gv 2016 GP LLC2.45%3,125,312$79.82MInsider
Gv 2017 GP LLC1.51%1,924,474$49.15MInsider
Hadley Harbor Master Investors Cayman II LP1.18%1,496,813$38.23MInsider
Juan C. Jaen0.94%1,200,531$30.66MInsider
Yasunori Kaneko0.75%957,955$24.47MInsider
Column Group II LP0.37%470,427$12.01MInsider
Jennifer Jarrett0.18%224,024$5.72MInsider
Carolyn C. Tang0.14%184,607$4.71MInsider

1 of 3

RCUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCUS0.10%44.15%Net SellingNet Selling
VCYT0.11%53.43%Net SellingNet Selling
DYN0.10%20.12%Net SellingNet Selling
ARQT0.10%30.68%Net SellingNet Selling
DNLI0.10%57.28%Net SellingNet Selling

Arcus Biosciences Stock Ownership FAQ

Who owns Arcus Biosciences?

Arcus Biosciences (NYSE: RCUS) is owned by 0.10% institutional shareholders, 44.15% Arcus Biosciences insiders, and 55.75% retail investors. Gilead Sciences Inc is the largest individual Arcus Biosciences shareholder, owning 31.42M shares representing 24.68% of the company. Gilead Sciences Inc's Arcus Biosciences shares are currently valued at $793.16M.

If you're new to stock investing, here's how to buy Arcus Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.